Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M. Letizia Lo Faro"'
Autor:
Pommelien Meertens, Azita Mellati, Richard Dumbill, M. Letizia Lo Faro, Kaithlyn Rozenberg, John Mulvey, Hans Fliri, Rutger Ploeg, James Hunter
Publikováno v:
Frontiers in Transplantation, Vol 2 (2023)
IntroductionCurrently there is an urgent need to translate interventions that may be beneficial to marginal donor kidneys prior to transplant, to improve their quality from bench to bedside. This project investigated the effects of CC-4066, a potent
Externí odkaz:
https://doaj.org/article/3f6eb3fc42354483ae2a357f4ed961db
Autor:
Benedikt M. Kessler, Rutger J. Ploeg, M. Letizia Lo Faro, Peter J. Friend, Honglei Huang, Tomas Surik, Constantin C. Coussios, Annemarie Weissenbacher
Publikováno v:
American Journal of Transplantation
We describe a proteomics analysis to determine the molecular differences between normothermically perfused (normothermic machine perfusion, NMP) human kidneys with urine recirculation (URC) and urine replacement (UR). Proteins were extracted from 16
Autor:
M. Letizia Lo Faro, Paul Eggleton, Paul G. Winyard, Richard C Haigh, Jennifer A. Littlechild, Matthew Whiteman, Joanna M. Tarr, Katalin Szabó-Taylor, Carly A.L. Turner, Sára Tóth
Publikováno v:
The International Journal of Biochemistry & Cell Biology
Peroxiredoxin 2 has immune regulatory functions, but its expression in human peripheral blood lymphocytes and levels in extracellular fluid in healthy subjects and rheumatoid arthritis patients are poorly described. In the present study, the median i
Autor:
Fenna E M van de Leemkolk, M Letizia Lo Faro, Sadr Shaheed, John F Mulvey, Volkert A L Huurman, Ian P J Alwayn, Hein Putter, Ina Jochmans, Jan H N Lindeman, Rutger J Ploeg, COMPARE Trial Collaboration and the Consortium for Organ Preservation in Europe (COPE)
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0287713 (2023)
Hypothermic machine perfusion (HMP) provides preservation superior to cold storage and may allow for organ assessment prior to transplantation. Since flavin mononucleotide (FMN) in perfusate has been proposed as a biomarker of organ quality during HM
Externí odkaz:
https://doaj.org/article/4607a144b8e7400999816a3cc32ebf7c